Cisema Presented on China NMPA Approval Pathways & GBA Opportunities During Hong Kong Healthcare Week
The UK Department for Business and Trade (DBT) Guangzhou hosted a networking dinner in Shenzhen as part of the Hong Kong Healthcare Week mission program. The event brought together UK medtech and lifesciences companies visiting the Greater Bay Area (GBA) for networking and knowledge exchange focused on China’s healthcare and life sciences sector..
As part of the program, Jacky Li, VP for Hong Kong, Macau, and the Greater Bay Area at Cisema, delivered a presentation on China medical product registration and regional pilot policies relevant to international companies exploring the market.
Cisema Presentation: China NMPA Approval Pathways for Medical Products
The presentation outlined key considerations for medical product registration in China, with a focus on approval pathways, and cross-border healthcare initiatives.
Topics covered included:
- General NMPA registration pathways
- Pharmaceutical and medical device approval processes in China
- Regulatory opportunities within the Greater Bay Area (GBA)
- Developments and pilot initiatives in the Hainan Boao Lecheng International Medical Tourism Pilot Zone
- Cross-border healthcare considerations for companies evaluating regional expansion